🔎 Trials Near Me

Akèy › Timè nan sèvo › Ohio › Columbus

Etid klinik pou Timè nan sèvo nan Columbus, OH

11 etid pou Timè nan sèvo ap chèche patisipan nan sit nan ak bò kote Columbus (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Ap rekriteFaz 2
  • Ohio State University, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT07326566

SRS & Abemaciclib w/wo Imlunestrant in the Management of HR+/HER2- Breast CA Brain Metastases

Ap rekriteFaz 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 28, 2026 · NCT04923542

A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases

Ap rekriteFaz 2
  • Ohio State University Comprehensive Cancer Center, Columbus
  • Mount Carmel East Hospital, Columbus
  • Columbus Oncology and Hematology Associates Inc, Columbus
  • ak 15 plis
Laj 18 ak plis · Tout sèks · Mizajou Sep 15, 2026 · NCT04511013

Targeted Pediatric High-Grade Glioma Therapy

Ap rekriteEtid obsèvasyon
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Tout sèks · Mizajou Sep 8, 2026 · NCT05839379

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Ap rekriteFaz 2
  • The Ohio State University College of Medicine (OSUCOM), Columbus
Laj 18 ak plis · Tout sèks · Mizajou Sep 8, 2026 · NCT07428616

Study of Olutasidenib and Temozolomide in HGG

Ap rekriteFaz 2
  • Nationwide Children's Hospital, Columbus
Laj 12 a 39 · Tout sèks · Mizajou Sep 1, 2026 · NCT06161974

Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).

Ap rekriteFaz 2
  • Nationwide Children's Hospital, Columbus
Laj 1 a 26 · Tout sèks · Mizajou Aug 4, 2026 · NCT07680439

Natural Killer Cell Therapy (UD TGFbetai NK Cells) and Temozolomide for the Treatment of Stage IV Melanoma Metastatic to the Brain

Ap rekriteFaz 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Jun 11, 2026 · NCT05588453

Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant

Ap rekriteFaz 2
  • Nationwide Children's Hospital, Columbus
12 Months – 39 Years · Tout sèks · Mizajou May 29, 2026 · NCT05843253

Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss

Ap rekriteFaz 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Apr 13, 2026 · NCT06810544

Delayed or Upfront Brain RAdiotherapy in Treatment naïve Lung Cancer Patients With Asymptomatic or Minimally Symptomatic Brain Metastases and ALK rEarrangements

Ap rekriteFaz 1/2
  • Ohio State University Comprehensive Cancer Center, Columbus
Laj 18 ak plis · Tout sèks · Mizajou Apr 8, 2026 · NCT05987644

Etid Timè nan sèvo nan lòt vil

Lòt etid nan Columbus

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.